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Background
The development of foot ulcers is a serious complica-
tion in elderly diabetic patients. Its treatment is based
on the use of different techniques, but when they fail
that often lead to limb amputation. The efficacy of
treatment with HBOT in diabetic foot ulcer has been
evaluated for more than 20 years, but its use has never
become routine, its use is a reality that in recent years
is increasingly consolidating, especially as an adjuvant to
conventional therapies and the NPWT (Negative Pres-
sure Wound Therapy ) and dermal substitutes. Many
studies prove its validity, experimentally the beneficial
effects consist in the improvement of tissue perfusion,
inflammatory cytokines down-regulation, fibroblasts
proliferation, edema reduction , angiogenesis promotion
and collagen production, it is also proven by the years
the favorable effect against infectious component of
the lesion [1,2]. In particular, the hyperbaric oxygen
increases the bactericidal activity and is particularly
toxic to anaerobes [3]. In addition, many studies,
including some meta-analyzes, documenting the positive
role of HBOT in reducing the risk of amputation,
although a recent meta-analysis it is clear the short-
term benefit, but for the long-term studies would be
needed to be so designated such as to minimize any
bias [4]5.
In our center, we evaluated the use of hyperbaric oxy-
gen therapy to reduce limb amputation risk.
Methods
This observational study, open-label short-term evaluated
the clinical efficacy of this method integrated medical
therapy, treatment of wound cleansing and debridement,
and topical applications of hydrocolloids, alginates, polya-
crylates and foams. After obtaining informed consents, 7
diabetic patients with foot ulcers (n = 7) were enrolled
and treated with cycles of hyperbaric oxygen therapy
(2.4 ATA) for a period of about 85 minutes for 5 days a
week, during the period between January and September
2012, with follow-up until May 2013.Among the exclu-
sion criteria we considered: patients with compromised
bone and / or Charcot’s foot, Wagner class greater than
III, non elegible patients for HBOT (AP chest X-ray, visit
ENT, cardiological examination with ECG, laboratory
tests to assess feasibility), then patients with severe
impairment of arterial district in the affected arm. All
patients have done foot X-ray and ECO Color Doppler of
lower limb as preliminary study, which showed: four
patients Wagner class II, Winsor index between 0.9 and
1, three patients Wagner Class III, with winsor pathologi-
cal index. The treatment was carried out in two stages: at
first, the patients were treated with medical therapy, sur-
gical debridement, exudate management and stimulation
of granulation and epithelialization with advanced wound
dressings, wound swabs and orthotics , in a second time
were matched HBOT cycles. The follow-up was done by
clinical and biochemical controls with particular atten-
tion to the glycemic profile and obtaining optimal levels
of glycated hemoglobin, and taking cilostazol tablets 100
mg, possibly associated with antiplatelets (cardioaspirin,
clopidogrel). We established two outcome measures : 1)
surgical healing of the lesions, 2) amputation (short-term
assessment by the end of treatment until May 2013).
* Correspondence: luciano.grimaldi@unina.it
1Department of Specialized Surgery, Division of Gastrointestinal Surgery
Rehabilitation of Election and Emergency. “Federico II” University, Naples,
Italy
Full list of author information is available at the end of the article
Grimaldi et al. BMC Surgery 2013, 13(Suppl 1):A26
http://www.biomedcentral.com/1471-2482/13/S1/A26
© 2013 Grimaldi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Results
The demographic characteristics of our analyzed sample
: 5M, 2F, all type II diabetic patients, mean age 66 years.
On the basis of our preliminary data, we observed that
3 patients needed just two weeks of HBOT, while other
2 ones needed 4 weeks to get the necessary surgical
healing of the lesions, seen as complete epithelial regen-
eration, also evaluated with ultrasound of the foot to
highlight the possible persistence of outbreaks internal
abscess. Other 2 patients required 6 weeks of HBOT.
There were no adverse events. After almost a year, no
one has suffered amputation of the limb and in only
one case it was observed ulcer recurrence, in January
2013 , treated with the same method, and healed in
6 weeks of treatment.
Conclusions
The management and treatment of foot ulcers in dia-
betic patients often require months of medical and sur-
gical therapy, but if HBOT is associated the healing
process takes place in less time, and this may even
reduce the cost for the National Health System, despite
the HBOT cycles are expensive. Currently, therefore, we
can say that a lot of data available from international
studies show that hyperbaric oxygen is excellent and
valuable support in the healing process in patients with
ulcer formed, and even though preliminary results of
our study confirm this trend. We have to say that
further studies are needed to validate the results
obtained in the long term, and that the risk of amputa-
tion breakdown in these patients is the result of an
intensive follow-up with a focus on medical therapy for
good glycemic control and a good cardiovascular pre-
vention, the pathophysiological processes key that con-
tribute to determine these pathological lesions.
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